Navigation Links
Intarcia Therapeutics, Inc. Presents Positive Results of ITCA 650 Phase 1b Study in Type 2 Diabetes at the European Association for the Study of Diabetes Conference
Date:9/30/2009

---------------------- % HbA1c at baseline 7.67 7.90 7.45 7.38 -------------------------------------------------------------------------- % HbA1c at end of treatment 7.15 7.28 7.00 6.80 -------------------------------------------------------------------------- Change from baseline -0.54* -0.62* -0.45* -0.73* -------------------------------------------------------------------------- Mean change in weight (kg) -0.27 -0.28 -1.13 -3.09* -------------------------------------------------------------------------- *p = < 0.05

Although the treatment duration in the study was only 28 days, decreases in HbA1c and body weight were observed across all dose arms. Changes in HbA1c from baseline were statistically significant across all treatment arms. The most commonly reported adverse events were nausea and vomiting which were mostly mild, transient, dose dependent and limited to the first week of therapy.

"We've been very pleased with the positive results of this study and rapid progress in the ITCA 650 development program," said K. Alice Leung, President and CEO of Intarcia. "Within just 4 months of completing the phase 1b study, Intarcia began enrollment of an ongoing phase 2 study comparing ITCA 650 with twice-daily Byetta® (exenatide) injection among 150 patients with type 2 diabetes over a 3-month treatment period."

The phase 2 trial will evaluate ITCA 650 against the current standard of care for a longer duration of treatment and among a larger population of type 2 diabetes patients. The goals of the ITCA 650 program are to enhance the therapeutic effects of exenatide by ensuring patient compliance and providing more consistent, around-the-clock therapeutic drug levels, and to reduce side effects, including nausea associated with high peak levels of exenatide exposure observed with
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Intarcia Therapeutics, Inc. Announces Appointment of Kenneth Luskey, M.D. as Vice President, Clinical Research
2. Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions
3. Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions
4. Intarcia Therapeutics, Inc. Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes
5. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
6. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
7. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
8. Nile Therapeutics, Inc. Adds to Executive Management Team
9. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
10. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
11. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... Alanda Software, a leading global ... announced today that a top tier global biopharmaceutical ... solution in both the U.S. and EU markets. ... Data Quality remediation portal, designed to help both ... improve their ability to capture, transmit and receive ...
(Date:11/18/2014)... Ft. Lauderdale, FL (PRWEB) November 18, 2014 ... 12) have announced the launch of PAWSitively Curing ... Awareness Month. This new 501(c) (3) non-profit organization is ... Every dollar donated goes directly to the University ... proud to partner with PAWSitively Curing Cancer as the ...
(Date:11/18/2014)... November 18, 2014 Array Architects is ... design expertise to the nation's hospitals and health systems. ... by those dedicating their careers to the advancement of ... contributor in her respective field, Laura Silvoy has been ... the 2014 Winter Simulation Conference. , Laura will ...
(Date:11/18/2014)... , Nov. 18, 2014  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... progenitor cells) for complete cervical spinal cord injury ... "Top Advanced Therapies Projects to Watch" by Elsevier ... receive this significant industry honor, which represents independent ...
Breaking Biology Technology:Alanda Software Completes Successful Implementation of Global Data Quality & Vendor Management Solution for Top Tier Global Biopharmaceutical Company 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 3Array Healthcare Simulation Expert Slated to Speak at Winter Simulation Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 2Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic Area Partnerships Conference 3
... Wis. - Avolte Venture Partners Midwest, a venture capital ... says it has reached its initial goal for raising capital ... and the Midwest. , ,The fund, which was to be ... but has raised enough for an initial close, according to ...
... - The winding roads and hilly terrain outside this ... River suggest agriculture or tourism, not high technology. But ... a wrong turn reveals a surprising destination. , ,In a ... over the bluffs, sits the Phillips Plastics Corp. Technology ...
... Corp ., a non-profit development company that helps small businesses, ... technology businesses. , ,MDC said it has closed on loans ... off of Lucigen Corp. , and to BioSystem ... Contest. , ,C5-6 Technologies, which will develop enzymes used to ...
Cached Biology Technology:Avolte Venture Partners reaches capital goal 2In western Wisconsin, the innovation economy is growing 2In western Wisconsin, the innovation economy is growing 3
(Date:11/4/2014)... (November 4, 2014) — Think about the way our ... do neighboring cells know that they are supposed to ... do these tissues find the correct place and alignment? ... these crucial questions. , In a new study, UM ... communicate with their surrounding neighbors, at the head-trunk region. ...
(Date:11/4/2014)... 2014) – A majority of Madagascar,s 101 species of ... serious consequences for the rainforests they call home. A ... impacts lemurs can have on rainforest tree populations, which ... have on the region,s rich biodiversity. , A large ... by lemurs. Lemurs in turn disperse the seeds ...
(Date:11/3/2014)... A University of Colorado Cancer Center study ... Academy of Sciences describes the activity of a ... Interleukin 37 or IL-37. It has been known to ... in the adaptive immune system: IL-37 inhibits the ability ... antigens. , "Knowing this mechanism that underlies IL-37,s effect ...
Breaking Biology News(10 mins):The inside story: How the brain and skull stay together 2Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3PNAS: From HIV to cancer, IL-37 regulates immune system 2
... on genes to help cells survive low-oxygen conditions also slows ... the growth of new cells, Johns Hopkins researchers report. Their ... this copying known as DNA replication and new ... such diseases as cancer. , "We,ve long known that ...
... cockroaches start to recover from being shoved sideways before ... legs what to do, researchers have found. These new ... help engineers design steadier robots and improve doctors, understanding ... roaches were able to maintain their footing mechanicallyusing their ...
... February in Manchester, UK to map the progress and development of ... from the last 16 months, this meeting will focus on the ... be designated to the interface between the two projects to outline ... aim of the FP7 funded project BESAFE ...
Cached Biology News:Flipping the 'off' switch on cell growth 2Lessons from cockroaches could inform robotics 2Lessons from cockroaches could inform robotics 3BESAFE Conference in Manchester: Working towards a brighter future for biodiversity 2
...
Water Distilled (Gibco™) is membrane filtered and endotoxin screened....
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Biology Products: